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The oral mucosa is vascularized, drugs can be absorbed di-
rectly and can enter the systemic circulation without first-
pass metabolism [1]. This advantage can be used in preparing
products with increased oral bioavailability of molecules that
undergo first pass metabolism.Thus oral mucosa is an attrac-
tive site for drug delivery [2,3].The objective of this research
work is to formulate mouth dissolving film of nifedipine for
enhanced bioavailability. nifedipine is used to treat hyperten-
sion and angina pectoris.
In the present investigation, an attempt wasmade to develop
mouth dissolving films of nifedipine to achieve fast disinte-
gration and dissolution characteristics with improved
bioavailability by oral route. The drug & excipients were char-
acterized as per IP 2014. Drug and excipients studies were
conducted using FTIR. Oral films of nifedipine were formu-
lated using HPMC E5, PVP polymer as a film forming agent and
PEG-400 as plasticizer. The solvent casting method was used
for the preparation of films. A central composite design using
Design Expert Software was used to optimize and evaluate the
main effects, interaction effects and quadratic effects of the
formulation ingredients on the disintegration time & in vitro
drug release. A 2-factor, 2-level design was observed to be the
most suitable and appropriate for exploring quadratic re-
sponse surfaces and constructing second-order polynomial
models. nifedipine oral film was evaluated for folding endur-
ance, thickness, weight variation test, surface pH, content
uniformity, disintegration test, & in vitro dissolution. The sta-
bility studies of the films were performed for optimized batch
as per ICH guideline.
No drug–excipients interaction was observed. The charac-
terization studies depict the purity of drug & all the excipients
used in the formulation. The IR spectrum of mixture of
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nifedipine with all other excipients does not show any changes
which indicates its compatibility with other excipients. As per
DOE 11 different formulation trials were carried out. The op-
timized batch showed a disintegration time of 30 seconds &
maximum % drug release was within 60 seconds as shown in
Fig. 1.
From the results, it can be concluded that the fast dissolv-
ing oral film of nifedipine showed fast disintegration dissolution
of drugs in salivary pH.Thus the prepared fast dissolving films
of nifedipine could be a better alternative for achieving rapid
oral bioavailability in angina pectoris.
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Fig. 1 – Contour plot (a) and 3D surface plot (b).
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